J B Chemicals and Pharmaceuticals Ltd
JBCHEPHARM (NSE)

1,660.45

12,832.31
Proj. ROE (%)
22.34
Proj. P/E (x)
28.37
Proj EV / EBITDA (x)
21.61
Proj. P/BV (x)
4.76
Proj. Revenue ( Cr.)
2,383.84

Stock View

BUY
Share on
The average score for J B Chemicals and Pharmaceuticals Ltd stands at 7 against 9, three months back.

J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. It is an integrated, research-oriented organization, which is focused on supplying products both in India and International markets. The Company manufactures and markets a range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredient (APIs). The Company is engaged in manufacturing specialty products that include various pharmaceutical dosage forms like tablets, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, liquids and capsules. The Company’s brands include Cilacar (calcium channel blocker), Rantac (anti-peptic ulcerant), Nicardia (calcium channel blocker) and Metrogyl (amoebicides).

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
1,737.43
100 DMA ()
1,756.72
200 DMA ()
1,538.42
52 Weeks Range
940.00
1,985.00
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity